Donepezil Industry Research Report 2024

Donepezil Industry Research Report 2024


North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.

Donepezil's major manufacturers include Eisai, Pfizer, Teva, Novartis, etc. The top three companies account for about 60% of the market.

According to APO Research, the global Donepezil market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

The classification of Donepezil includes 5mg, 10mg and 23mg, and the proportion of 10mg in 2017 is about 48%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Donepezil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Donepezil.

The report will help the Donepezil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Donepezil market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Donepezil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Eisai
Pfizer
Teva
Sandoz
Apotex
Dr Reddy's Laboratories
Sun Pharmaceutical
Hansoh Pharma
Cipla
ARK PHA.LTD
Jishengtang Pharma
Luoxin

Donepezil segment by Type
5mg
10mg
23mg

Donepezil segment by Application
Hospitals
Clinics
Drugstore

Donepezil Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Donepezil and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Donepezil manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Donepezil by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Donepezil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Donepezil Market Size (2019-2030) & (US$ Million)
2.2.2 Global Donepezil Sales (2019-2030)
2.2.3 Global Donepezil Market Average Price (2019-2030)
2.3 Donepezil by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 5mg
2.3.3 10mg
2.3.4 23mg
2.4 Donepezil by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Hospitals
2.4.3 Clinics
2.4.4 Drugstore
3 Market Competitive Landscape by Manufacturers
3.1 Global Donepezil Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Donepezil Sales (M Units) of Manufacturers (2019-2024)
3.3 Global Donepezil Revenue of Manufacturers (2019-2024)
3.4 Global Donepezil Average Price by Manufacturers (2019-2024)
3.5 Global Donepezil Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Donepezil, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Donepezil, Product Type & Application
3.8 Global Manufacturers of Donepezil, Date of Enter into This Industry
3.9 Global Donepezil Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Eisai
4.1.1 Eisai Company Information
4.1.2 Eisai Business Overview
4.1.3 Eisai Donepezil Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Eisai Donepezil Product Portfolio
4.1.5 Eisai Recent Developments
4.2 Pfizer
4.2.1 Pfizer Company Information
4.2.2 Pfizer Business Overview
4.2.3 Pfizer Donepezil Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Pfizer Donepezil Product Portfolio
4.2.5 Pfizer Recent Developments
4.3 Teva
4.3.1 Teva Company Information
4.3.2 Teva Business Overview
4.3.3 Teva Donepezil Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Teva Donepezil Product Portfolio
4.3.5 Teva Recent Developments
4.4 Sandoz
4.4.1 Sandoz Company Information
4.4.2 Sandoz Business Overview
4.4.3 Sandoz Donepezil Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Sandoz Donepezil Product Portfolio
4.4.5 Sandoz Recent Developments
4.5 Apotex
4.5.1 Apotex Company Information
4.5.2 Apotex Business Overview
4.5.3 Apotex Donepezil Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Apotex Donepezil Product Portfolio
4.5.5 Apotex Recent Developments
4.6 Dr Reddy's Laboratories
4.6.1 Dr Reddy's Laboratories Company Information
4.6.2 Dr Reddy's Laboratories Business Overview
4.6.3 Dr Reddy's Laboratories Donepezil Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Dr Reddy's Laboratories Donepezil Product Portfolio
4.6.5 Dr Reddy's Laboratories Recent Developments
4.7 Sun Pharmaceutical
4.7.1 Sun Pharmaceutical Company Information
4.7.2 Sun Pharmaceutical Business Overview
4.7.3 Sun Pharmaceutical Donepezil Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Sun Pharmaceutical Donepezil Product Portfolio
4.7.5 Sun Pharmaceutical Recent Developments
4.8 Hansoh Pharma
4.8.1 Hansoh Pharma Company Information
4.8.2 Hansoh Pharma Business Overview
4.8.3 Hansoh Pharma Donepezil Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Hansoh Pharma Donepezil Product Portfolio
4.8.5 Hansoh Pharma Recent Developments
4.9 Cipla
4.9.1 Cipla Company Information
4.9.2 Cipla Business Overview
4.9.3 Cipla Donepezil Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Cipla Donepezil Product Portfolio
4.9.5 Cipla Recent Developments
4.10 ARK PHA.LTD
4.10.1 ARK PHA.LTD Company Information
4.10.2 ARK PHA.LTD Business Overview
4.10.3 ARK PHA.LTD Donepezil Sales, Revenue and Gross Margin (2019-2024)
4.10.4 ARK PHA.LTD Donepezil Product Portfolio
4.10.5 ARK PHA.LTD Recent Developments
4.11 Jishengtang Pharma
4.11.1 Jishengtang Pharma Company Information
4.11.2 Jishengtang Pharma Business Overview
4.11.3 Jishengtang Pharma Donepezil Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Jishengtang Pharma Donepezil Product Portfolio
4.11.5 Jishengtang Pharma Recent Developments
4.12 Luoxin
4.12.1 Luoxin Company Information
4.12.2 Luoxin Business Overview
4.12.3 Luoxin Donepezil Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Luoxin Donepezil Product Portfolio
4.12.5 Luoxin Recent Developments
5 Global Donepezil Market Scenario by Region
5.1 Global Donepezil Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Donepezil Sales by Region: 2019-2030
5.2.1 Global Donepezil Sales by Region: 2019-2024
5.2.2 Global Donepezil Sales by Region: 2025-2030
5.3 Global Donepezil Revenue by Region: 2019-2030
5.3.1 Global Donepezil Revenue by Region: 2019-2024
5.3.2 Global Donepezil Revenue by Region: 2025-2030
5.4 North America Donepezil Market Facts & Figures by Country
5.4.1 North America Donepezil Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Donepezil Sales by Country (2019-2030)
5.4.3 North America Donepezil Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Donepezil Market Facts & Figures by Country
5.5.1 Europe Donepezil Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Donepezil Sales by Country (2019-2030)
5.5.3 Europe Donepezil Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Donepezil Market Facts & Figures by Country
5.6.1 Asia Pacific Donepezil Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Donepezil Sales by Country (2019-2030)
5.6.3 Asia Pacific Donepezil Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Donepezil Market Facts & Figures by Country
5.7.1 Latin America Donepezil Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Donepezil Sales by Country (2019-2030)
5.7.3 Latin America Donepezil Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Donepezil Market Facts & Figures by Country
5.8.1 Middle East and Africa Donepezil Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Donepezil Sales by Country (2019-2030)
5.8.3 Middle East and Africa Donepezil Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Donepezil Sales by Type (2019-2030)
6.1.1 Global Donepezil Sales by Type (2019-2030) & (M Units)
6.1.2 Global Donepezil Sales Market Share by Type (2019-2030)
6.2 Global Donepezil Revenue by Type (2019-2030)
6.2.1 Global Donepezil Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Donepezil Revenue Market Share by Type (2019-2030)
6.3 Global Donepezil Price by Type (2019-2030)
7 Segment by Application
7.1 Global Donepezil Sales by Application (2019-2030)
7.1.1 Global Donepezil Sales by Application (2019-2030) & (M Units)
7.1.2 Global Donepezil Sales Market Share by Application (2019-2030)
7.2 Global Donepezil Revenue by Application (2019-2030)
7.2.1 Global Donepezil Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Donepezil Revenue Market Share by Application (2019-2030)
7.3 Global Donepezil Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Donepezil Value Chain Analysis
8.1.1 Donepezil Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Donepezil Production Mode & Process
8.2 Donepezil Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Donepezil Distributors
8.2.3 Donepezil Customers
9 Global Donepezil Analyzing Market Dynamics
9.1 Donepezil Industry Trends
9.2 Donepezil Industry Drivers
9.3 Donepezil Industry Opportunities and Challenges
9.4 Donepezil Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings